Virgil Craig Jordan
Affiliations: | 1980-1993 | University of Wisconsin, Madison, Madison, WI | |
1993-2005 | Northwestern University Medical School, Chicago, IL, United States | ||
2005-2014 | Fox Chase Cancer Center | ||
2014- | University of Texas MD Anderson Cancer Center, Houston, TX, United States |
Area:
tamoxifenWebsite:
https://gsbs.uth.edu/faculty/faculty-directory/faculty-profiles.htm?id=45f66488-5324-487d-abe2-d9890cb8b760Google:
"Virgil Craig Jordan"Bio:
http://www.nasonline.org/member-directory/members/20020248.html
DOI: 10.1073/pnas.1117698108
https://mdanderson.influuent.utsystem.edu/en/persons/virgil-craig-jordan
https://www.mdanderson.org/publications/cancer-frontline/2017/10/pioneering-breast-cancer-researcher-v--craig-jordan-elected-to-t.html
https://uwm.edu/chemistry/outreach/george-and-christine-sosnovsky-lectureship-series/craig-jordan/
(Show more)
Mean distance: (not calculated yet)
Parents
Sign in to add mentorEdward Raymond Clark | grad student | 1972 | University of Leeds | |
(A Study of the Oestrogenic and Anti-oestrogenic Activities of Some Substituted Triphenylethylenes and Triphenylethanes.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Jordan VC. (2020) Molecular Mechanism for Breast Cancer Incidence in the Women's Health Initiative. Cancer Prevention Research (Philadelphia, Pa.). 13: 807-816 |
Maximov PY, Abderrahman B, Hawsawi YM, et al. (2020) The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells. Molecular Pharmacology |
Sweeney EE, Fan P, Jordan VC. (2014) Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study. Cancer Research. 74: 7060-8 |
Obiorah IE, Fan P, Sengupta S, et al. (2014) Selective estrogen-induced apoptosis in breast cancer. Steroids. 90: 60-70 |
Obiorah IE, Jordan VC. (2014) Differences in the rate of oestrogen-induced apoptosis in breast cancer by oestradiol and the triphenylethylene bisphenol. British Journal of Pharmacology. 171: 4062-72 |
Obiorah I, Sengupta S, Curpan R, et al. (2014) Defining the conformation of the estrogen receptor complex that controls estrogen-induced apoptosis in breast cancer. Molecular Pharmacology. 85: 789-99 |
Hu ZZ, Kagan BL, Ariazi EA, et al. (2011) Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells. Plos One. 6: e20410 |
Maximov P, Sengupta S, Lewis-Wambi JS, et al. (2011) The Conformation of the Estrogen Receptor Directs Estrogen-Induced Apoptosis in Breast Cancer: A Hypothesis. Hormone Molecular Biology and Clinical Investigation. 5: 27-34 |
Jordan VC, Ford LG. (2011) Paradoxical clinical effect of estrogen on breast cancer risk: a "new" biology of estrogen-induced apoptosis. Cancer Prevention Research (Philadelphia, Pa.). 4: 633-7 |
Sengupta S, Sharma CG, Jordan VC. (2010) Estrogen regulation of X-box binding protein-1 and its role in estrogen induced growth of breast and endometrial cancer cells. Hormone Molecular Biology and Clinical Investigation. 2: 235-243 |